83P Exoxomes and miRNA in breast cancer cancerogenesis: A case-control study
Bárbara Cardinali(Ospedale Policlinico San Martino), Lucia Del Mastro(Ospedale Policlinico San Martino), Giovanna Chiorino(Fondazione Edo ed Elvo Tempia), Paola Ostano(Fondazione Edo ed Elvo Tempia), Zita Cavalieri(Ospedale Policlinico San Martino), Roberta Tasso(Azienda Ospedaliera S.Maria), Patrizia Piccioli(Ospedale Policlinico San Martino), Cristina Bruzzo(Ospedale Policlinico San Martino), Simona Coco(Ospedale Policlinico San Martino), A. Rubagotti(University of Genoa), Linda Zinoli(Ospedale Policlinico San Martino), Andrea Sciutto(Ospedale Policlinico San Martino), Davide Ceresa(Ospedale Policlinico San Martino), Paolo Malatesta(Ospedale Policlinico San Martino), Rodolfo Quarto(Ospedale Policlinico San Martino), Francesco Boccardo(University of Genoa)
Cited by 1
Related Papers
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|Cancer Treatment Reviews|2018|282
CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
|Frontiers in Oncology|2018|205